[Federal Register Volume 80, Number 32 (Wednesday, February 18, 2015)]
[Notices]
[Pages 8659-8660]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-03244]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-0556]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Assisted Reproductive Technology (ART) Program Reporting System
(OMB No. 0920-0556, expires 8/31/2015)--Revision--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Section 2(a) of Public Law 102-493 (known as the Fertility Clinic
Success Rate and Certification Act of 1992 (FCSRCA), 42 U.S.C. 263a-
1(a)), requires that each assisted reproductive technology (ART)
program shall annually report to the Secretary through the Centers for
Disease Control and Prevention: (1) pregnancy success rates achieved by
such ART program, and (2) the identity of each embryo laboratory used
by such ART program and whether the laboratory is certified or has
applied for such certification under the Act. Information is
transmitted to CDC electronically through the Web-based National ART
Surveillance System (NASS) or NASS-compatible files extracted from
other record systems. CDC requests OMB approval to continue information
collection for three years, with changes that will be phased in during
this period.
Information collection will continue under currently approved
procedures through December 31, 2015. Revised reporting requirements
are planned for ART cycles initiated on or after January 1, 2016. The
proposed changes reflect CDC's ongoing dialogue with subject matter
experts including partner organizations and the data collection
contractor. These consultations identify changes to the NASS data
elements that are essential to keep pace with changes in medical
practice and other opportunities for improvement. The proposed changes
to the NASS data elements will ensure that reported success rates
reflect standardized data definitions and provide additional insight
into factors that may affect success rates. Concurrent with changes to
data elements, the NASS data entry pages will be redesigned for more
intuitive grouping of data items and improved skip logic that will
route users to the minimum number of applicable questions. Finally, CDC
will continue to collect feedback from ART clinics on NASS reporting
procedures. Participation in the brief Feedback
[[Page 8660]]
Survey is voluntary and is not required by the FCSRCA.
During the period of this Revision, estimated annualized burden
will increase due to an anticipated increase in the number of
responding clinics, an anticipated increase in the average number of
ART cycles reported by each clinic, and a modest increase in the
estimated burden per response for reporting each ART cycle. The
Revision request also includes a one-time allocation of 40 burden hours
per clinic. This allocation acknowledges the time needed to deploy the
updated NASS platform and train staff on revised reporting
requirements.
The collection of ART cycle information allows CDC to publish an
annual report to Congress as specified by the FCSRCA and to provide
information needed by consumers. Overall, the proposed changes will
support CDC's ability to generate timely, accurate, and relevant
information about fertility clinic success rates and improve user
satisfaction with the NASS interface.
OMB approval is requested for three years. The total estimated
annualized burden hours are 116,425. There are no costs to respondents
other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average number Average burden
Respondents Form name Number of of responses per response
respondents per respondent (in hours)
----------------------------------------------------------------------------------------------------------------
ART Clinics..................................... NASS 447 353 42/60
Feedback 335 1 2/60
Survey
One-time 149 1 40
System
Deployment
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-03244 Filed 2-17-15; 8:45 am]
BILLING CODE 4163-18-P